Crystal structure of an intact human IgG: Antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design

Advances in Experimental Medicine and Biology

Volumn 535, Issue , 2002, Pages 55-66

  Saphire, Erica Ollmann ^a   Stanfield, Robyn L ^a   Crispin, M D Max ^a,b   Morris, Garrett ^a   Zwick, Michael B ^a   Pantophlet, Ralph A ^a   Parren, Paul W H I ^c   Rudd, Pauline M ^b   Dwek, Raymond A ^b   Burton, Dennis R ^a   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GENMAB   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G;

ANTIBODY COMBINING SITE; CARBOHYDRATE ANALYSIS; CONFERENCE PAPER; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

AIDS VACCINES; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; GLYCOSYLATION; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; PROTEIN STRUCTURE, TERTIARY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 9144272243     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (57)

1. Barbas, C.F., III, Collet, T.A., Amberg, W., Roben, P., Binley, J.M., Hoekstra, D., Cababa, D., Jones, T.M., Williamson, R.A., Pilkington, G.R. et al., 1993, Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries, JMB. 230:812-823.
2. Barbas, C.F., III, Crowe, J.E., Jr., Cababa, D., Jones, T.M., Zebedee, S.L., Murphy, B.R., Chanock, R.M., and Burton, D.R., 1992, Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity, PNAS. 89:10164-10168.
3. Binley, J.M., Wyatt, R., Desjardins, E., Kwong, P.D., Hendrickson, W., Moore, J.P., and Sodroski, J., 1998, Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120, AIDS Res Hum Retroviruses. 14:191-198.
4. Burton, D.R., 1985, Immunoglobulin G: Functional Sites, Ml Immunol. 22:161-206.
5. Burton, D.R., 1990, Antibody: The flexible adaptor molecule, Trends Bioch Sci. 15:64-69.
6. Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Parren, P.W., Sawyer, L.S., Hendry, R.M., Dunlop, N., Nara, P.L. et al., 1994, Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody, Science. 266:1024-1027.
7. Burton, D.R., Saphire, E.O., and Parren, P.W.H.I., 2001, A model for neutralization of viruses based on antibody coating of the virion surface, Curr Topics in Microbiology and Immunology. 260:109-143.
8. Chan, D.C., Fass, D., Berger, J.M., and Kim, P.S., 1997, Core structure of gp41 from the HIV envelope glycoprotein, Cell. 89:263-273.
9. Colman, P.M., Deisenhofer, J., Huber, R., and Palm, W., 1976, Structure of the Human Antibody Molecule Kol (Immunoglobulin G1): An Electron Density Map at 5 Å Resolution, JMB. 100:257-278.
10. D'Souza, M.P., Durda, P., Hanson, C.V., and Milman, G., 1991, Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators, Aids. 5:1061-1070.
11. DeLano, W.L., Ultsch, M.H., de Vos, A.M., and Wells, J.A., 2000, Convergent solutions to binding at a protein-protein interface, Science. 287:1279-1283.
12. 2 Fragment and the Intact Immunoglobulin, Biochemistry. 17:820-823.
13. Gauduin, M.C., Parren, P.W., Weir, R., Barbas, C.F., Burton, D.R., and Koup, R.A., 1997, Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1, Nat Med. 3:1389-1393.
14. Harris, L.J., Larson, S.B., Hasel, K.W., Day, J., Greenwood, A., and McPherson, A., 1995, The three-dimensional structure of an intact monoclonal antibody for canine lymphoma, Nature. 360:369-372.
15. Harris, L.J., Larson, S.B., Hasel, K.W., and McPherson, A., 1997, Refined structure of an intact IgG2a monoclonal antibody, Biochemistry. 36:1581-1597.
16. Harris, L.J., Skaletsky, E., and McPherson, A., 1998, Crystallographic structure of an intact IgG1 monoclonal antibody, JMB. 275:861-872.
17. Kessler, J.A., 2nd, McKenna, P.M., Emini, E.A., Chan, C.P., Patel, M.D., Gupta, S.K., Mark, G.E., 3rd, Barbas, C.F., 3rd, Burton, D.R., and Conley, A.J., 1997, Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates, AIDS Res Hum Retroviruses. 13:575-582.
18. Kuhmann, S.E., Platt, E.J., Kozak, S.L., and Kabat, D., 2000, Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1, J Virol. 74:7005-7015.
19. Kunert, R., Ruker, F., and Katinger, H., 1998, Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5, AIDS Res Hum Retroviruses. 14:1115-1128.
20. Kwong, P.D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R.W., Sdroski, J., and Hendrickson, W.A., 2000a, Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates, Structure Fold Des. 8:1329-1339.
21. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J., and Hendrickson, W.A., 1998, Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody, Nature. 393:648-659.
22. Kwong, P.D., Wyatt, R., Sattentau, Q.J., Sodroski, J., and Hendrickson, W.A., 2000b, Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus, J Virol. 74:1961-1972.
23. Larson, S., Day, J., Greenwood, A., Skaletsky, E., and McPherson, A., 1991, Characterization of crystals of an intact monoclonal antibody for canine lymphoma, JMB. 222:17-19.
24. Marquart, M., Deisenhofer, J., and Huber, R., 1980, Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 Å and 1.9 Å resolution, JMB. 141:369-391.
25. Mascola, J.R., Lewis, M.G., Stiegler, G., Harris, D., VanCott, T.C., Hayes, D., Louder, M.K., Brown, C.R., Sapan, C.V., Frankel, S.S. et al., 1999, Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J Virol. 73:4009-4018.
26. Masuda, K., Yamaguchi, Y., Kato, K., Takahashi, N., Shimada, I., and Arata, Y., 2000, Pairing of oligosaccharides in the Fc region of immunoglobulin G, FEBS Lett. 473:349-357.
27. Moore, J.P. and Sodroski, J., 1996, Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein, J Virol. 70:1863-1872.
28. Moulard, M., Phogat, S.K., Shu, Y., Labrijn, A.F., Xiao, X., Binley, J.M., Zhang, M.Y., Sidorov, I.A., Broder, C.C., Robinson, J. et al., 2002, Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes, PNAS. 99:6913-6918.
29. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F., and Katinger, H., 1993, A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, J Virol. 67:6642-6647.
30. Myszka, D.G., Sweet, R.W., Hensley, P., Brigham-Burke, M., Kwong, P.D., Hendrickson, W.A., Wyatt, R., Sodroski, J., and Doyle, M.L., 2000, Energetics of the HIV gp120-CD4 binding reaction, PNAS. 97:9026-9031.
31. Pantophlet, R.A., Saphire, E.O., Poignard, P., Parren, P.W.H.I., Wilson, I.A., and Burton, D.R., 2003, Fine mapping of the interaction of neutralizing and non-neutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type I gp120, J Virol. 77:642-658.
32. Parren, P.W.H.I., Ditzel, H.J., Gulizia, R.J., Binley, J.M., Barbas, C.F., III, Burton, D.R., and Mosier, D.E., 1995, Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site, Aids. 9:F1-6.
33. Parren, P.W.H.I., Marz, P., Cheng-Mayer, C., Harouse, J., Moore, J.P., and Burton, D.R., 2001, Antibody protection of macaques against vaginal challenge with a pathogenic R5 HIV-1/SIV chimeric virus requires complete neutralization of HIV-1. J Virol. in press.
34. Parren, P.W.H.I., Mondor, I., Naniche, D., Ditzel, H.J., Klasse, P.J., Burton, D.R., and Sattentau, Q.J., 1998, Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity, J Virol. 72:3512-3519.
35. Parren, P.W.H.I., Moore, J.P., Burton, D.R., and Sattentau, Q.J., 1999, The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity, Aids. 13:S137-162.
36. Rajan, S.S., Ely, K.R., Abola, E.E., Wood, M.K., Colman, P.M., Athay, R.J., and Edmundson, A.B., 1983, Three-dimensional structure of the Meg IgG1 immunoglobulin, Ml Immunol. 20:787-799.
37. Roben, P., Moore, J.P., Thali, M., Sodroski, J., Barbas, C.F., 3rd, and Burton, D.R., 1994, Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1, J Virol. 68:4821-4828.
38. Rudd, P.M. and Dwek, R.A., 1997, Glycosylation: heterogeneity and the 3D structure of proteins, Crit Rev Biochem Mol Biol. 32:1-100.
39. Sanders, R.W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K.O., Kwong, P.D., and Moore, J.P., 2002, The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120, J Virol. 76:7293-7305.
40. Sanna, P.P., Williamson, R.A., De Logu, A., Bloom, F.E., and Burton, D.R., 1995, Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries, PNAS. 92:6439-6443.
41. Saphire, E.O., Montero, M., Menendez, A., Irving, M.B., Zwick, M.B., Parren, P.W.H.I., Burton, D.R., Scott, J.K., and Wilson, I.A., 2003, Crystal structure of a broadly neutralizing anti-HIV-1 antibody in complex with a peptide mimotope, submitted.
42. Saphire, E.O., Parren, P.W.H.I., Barbas, C.F., III, Burton, D.R., and Wilson, I.A., 2001a, Crystallization and preliminary structure determination of an intact human immunoglobulin b12: an antibody that broadly neutralizes primary isolates of HIV-1, Acta Cryst D57:168-171.
43. Saphire, E.O., Parren, P.W.H.I., Pantophlet, R., Zwick, M.B., Morris, G.M., Stanfield, R.L., Rudd, P.M., Dwek, R.A., Burton, D.R., and Wilson, I.A., 2001b, Crystal structure of an intact human IgG with broad and potent activity against primary HIV-1 isolates: A template for HIV vaccine design, Science. 293:1155-1159.
44. Saphire, E.O., Stanfield, R.L., Crispin, M.D., Rudd, P.M., Dwek, R.A., Parren, P.W.H.I., Burton, D.R., and Wilson, I.A., 2002, Contrasting IgG structures reveal extreme asymmetry and flexibility, JMB. 309:9-18.
45. Scanlan, C.N., Pantophlet, R., Wormald, M.R., Saphire, E.O., Stanfield, R., Wilson, I.A., Katinger, H., Dwek, R.A., Rudd, P.M., and Burton, D.R., 2002, The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1 → 2 mannose residues on the outer face of gp120, J Virol. 76:7306-7321.
46. Schønning, K., Lund, O., Lund, O.S., and Hansen, J.E., 1999, Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1, J Virol. 73:8364-8370.
47. Silverton, E.W., Navia, M.A., and Davies, D.R., 1977, Three-dimensional structure of an intact human immunoglobulin, PNAS. 74:5140-5144.
48. Smith, T.J., Chase, E.S., Schmidt, T.J., Olson, N.H., and Baker, T.S., 1996, Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon, Nature. 383:350-354.
49. Sondermann, P., Huber, R., Oosthuizen, V., and Jacob, U., 2000, The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex, Nature. 406:267-273.
50. Terry, W.D., Matthews, B.W., and Davies, D.R., 1968, Crystallographic studies of a human immunoglobulin, Nature. 220:239-241.
51. Trkola, A., Pomales, A.B., Yuan, H., Korber, B., Maddon, P.J., Allaway, G.P., Katinger, H., Barbas, C.F., 3rd, Burton, D.R., Ho, D.D. et al., 1995, Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG, J Virol. 69:6609-6617.
52. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J.P., and Katinger, H., 1996, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, J Virol. 70:1100-1108.
53. Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J., and Wiley, D.C., 1997, Atomic structure of the ectodomain from HIV-1 gp41, Nature. 387:426-430.
54. Wyatt, R. and Sodroski, J., 1998, The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens, Science. 280:1884-1888.
55. Zwick, M.B., Bonnycastle, L.L.C., Menendez, A., Irving, M.B., Barbas, C.F., III, Parren, P.W.H.I., Burton, D.R., and Scott, J.K., 2001a, Identification and characterization of a peptide that specifically binds the broadly HIV-1 neutralizing, human antibody, b12. J Virol. 75:6692-6699.
56. Zwick, M.B., Labrijn, A.F., Wang, M., Spenlehauer, C., Saphire, E.O., Binley, J.M., Moore, J.P., Steigler, G., Katinger, H., Burton, D.R., and Parren, P.W.H.I., 2001b, Broadly neutralizing antibodies targeted to the membrane-proximal region of Human Immunodeficiency Virus Type 1 Glycoprotein GP41, J Virol. 75:10892-10905.
57. Zwick, M.B., Parren, P.W.H.I., Saphire, E.O., Wang, M., Scott, J.K., Dawson, P.E., Wilson, I.A., and Burton, D.R., 2003, Molecular features of the broadly neutralizing antibody b12 required for recognition of HIV-1 Gp120, J Virol. 77:5863-5876.